Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, Thorsten O Goetze, Johannes Meiler, Stefan Kasper, Hans-Georg Kopp, Frank Mayer, Georg Martin Haag, Kim Luley, Udo Lindig, Wolff Schmiegel, Michael Pohl, Jan Stoehlmacher, Gunnar Folprecht, Stephan Probst, Nicole Prasnikar, Wolfgang Fischbach, Rolf Mahlberg, Jörg Trojan, Michael Koenigsmann, Uwe M Martens, Peter Thuss-Patience, Matthias Egger, Andreas Block, Volker Heinemann, Gerald Illerhaus, Markus Moehler, Michael Schenk, Frank Kullmann, Dirk M Behringer, Michael Heike, Daniel Pink, Christian Teschendorf, Carmen Löhr, Helga Bernhard, Gunter Schuch, Volker Rethwisch, Ludwig Fischer von Weikersthal, Jörg T Hartmann, Michael Kneba, Severin Daum, Karsten Schulmann, Jörg Weniger, Sebastian Belle, Timo Gaiser, Fuat S Oduncu, Martina Güntner, Wael Hozaeel, Alexander Reichart, Elke Jäger, Thomas Kraus, Stefan Mönig, Wolf O Bechstein, Martin Schuler, Harald Schmalenberg, Ralf D Hofheinz

Open source

DOI
10.1016/s0140-6736(18)32557-1
Published
2019-05
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-18-32557-1,
  title = {Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial},
  author = {Salah-Eddin Al-Batran and Nils Homann and Claudia Pauligk and Thorsten O Goetze and Johannes Meiler and Stefan Kasper and Hans-Georg Kopp and Frank Mayer and Georg Martin Haag and Kim Luley and Udo Lindig and Wolff Schmiegel and Michael Pohl and Jan Stoehlmacher and Gunnar Folprecht and Stephan Probst and Nicole Prasnikar and Wolfgang Fischbach and Rolf Mahlberg and Jörg Trojan and Michael Koenigsmann and Uwe M Martens and Peter Thuss-Patience and Matthias Egger and Andreas Block and Volker Heinemann and Gerald Illerhaus and Markus Moehler and Michael Schenk and Frank Kullmann and Dirk M Behringer and Michael Heike and Daniel Pink and Christian Teschendorf and Carmen Löhr and Helga Bernhard and Gunter Schuch and Volker Rethwisch and Ludwig Fischer von Weikersthal and Jörg T Hartmann and Michael Kneba and Severin Daum and Karsten Schulmann and Jörg Weniger and Sebastian Belle and Timo Gaiser and Fuat S Oduncu and Martina Güntner and Wael Hozaeel and Alexander Reichart and Elke Jäger and Thomas Kraus and Stefan Mönig and Wolf O Bechstein and Martin Schuler and Harald Schmalenberg and Ralf D Hofheinz},
  year = {2019},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(18)32557-1},
  url = {https://doi.org/10.1016/s0140-6736(18)32557-1}
}

RIS

TY  - JOUR
TI  - Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
AU  - Salah-Eddin Al-Batran
AU  - Nils Homann
AU  - Claudia Pauligk
AU  - Thorsten O Goetze
AU  - Johannes Meiler
AU  - Stefan Kasper
AU  - Hans-Georg Kopp
AU  - Frank Mayer
AU  - Georg Martin Haag
AU  - Kim Luley
AU  - Udo Lindig
AU  - Wolff Schmiegel
AU  - Michael Pohl
AU  - Jan Stoehlmacher
AU  - Gunnar Folprecht
AU  - Stephan Probst
AU  - Nicole Prasnikar
AU  - Wolfgang Fischbach
AU  - Rolf Mahlberg
AU  - Jörg Trojan
AU  - Michael Koenigsmann
AU  - Uwe M Martens
AU  - Peter Thuss-Patience
AU  - Matthias Egger
AU  - Andreas Block
AU  - Volker Heinemann
AU  - Gerald Illerhaus
AU  - Markus Moehler
AU  - Michael Schenk
AU  - Frank Kullmann
AU  - Dirk M Behringer
AU  - Michael Heike
AU  - Daniel Pink
AU  - Christian Teschendorf
AU  - Carmen Löhr
AU  - Helga Bernhard
AU  - Gunter Schuch
AU  - Volker Rethwisch
AU  - Ludwig Fischer von Weikersthal
AU  - Jörg T Hartmann
AU  - Michael Kneba
AU  - Severin Daum
AU  - Karsten Schulmann
AU  - Jörg Weniger
AU  - Sebastian Belle
AU  - Timo Gaiser
AU  - Fuat S Oduncu
AU  - Martina Güntner
AU  - Wael Hozaeel
AU  - Alexander Reichart
AU  - Elke Jäger
AU  - Thomas Kraus
AU  - Stefan Mönig
AU  - Wolf O Bechstein
AU  - Martin Schuler
AU  - Harald Schmalenberg
AU  - Ralf D Hofheinz
PY  - 2019
JO  - The Lancet
DO  - 10.1016/s0140-6736(18)32557-1
UR  - https://doi.org/10.1016/s0140-6736(18)32557-1
ER  -

APA

Al-Batran, S., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H., Mayer, F., Haag, G. M., Luley, K., Lindig, U., Schmiegel, W., Pohl, M., Stoehlmacher, J., Folprecht, G., Probst, S., Prasnikar, N., Fischbach, W., Mahlberg, R., Trojan, J., Koenigsmann, M., Martens, U. M., Thuss-Patience, P., Egger, M., Block, A., Heinemann, V., Illerhaus, G., Moehler, M., Schenk, M., Kullmann, F., Behringer, D. M., Heike, M., Pink, D., Teschendorf, C., Löhr, C., Bernhard, H., Schuch, G., Rethwisch, V., Weikersthal, L. F. V., Hartmann, J. T., Kneba, M., Daum, S., Schulmann, K., Weniger, J., Belle, S., Gaiser, T., Oduncu, F. S., Güntner, M., Hozaeel, W., Reichart, A., Jäger, E., Kraus, T., Mönig, S., Bechstein, W. O., Schuler, M., Schmalenberg, H., & Hofheinz, R. D. (2019). Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(18)32557-1

Source records